(Q40976934)

25 September 2017

title

Closing in on human immunodeficiency virus-1. (English)

1 reference

25 September 2017

Mellors JW

1

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

2

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

274-275

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0396-274

25 September 2017

exact match

0 references

cites work

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

HIV and multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

Preliminary analysis of the Concorde trial. Concorde Coordinating Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

inferred from DOI database lookup

7 January 2021

based on heuristic

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

inferred from DOI database lookup

7 January 2021

based on heuristic

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0396-274

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM0396-274

1 reference

25 September 2017

1 reference